Webinar Date/Time: Tue, Jul 25, 2023 9:00 AM EDT
This webcast aims to highlight the considerable evolution that was made with regards to chemical cleanliness of rubber components and their impact on extractables and leachables.
Register Free: https://www.pharmtech.com/pt_w/lockdown-lessons
Event Overview:
During the COVID-19 pandemic, supply chains around the world were disrupted, especially those in the pharmaceutical industry with the critical task of delivering life-saving vaccines worldwide. Three years after the start of the pandemic, the industry has learned valuable lessons for how to de-risk the supply chain and prepare for future emergent scenarios.
In this webcast, the audience will learn how COVID-19 impacted the pharmaceutical industry and drug supply, how to mitigate risk in the future, and how to create a future-proof supply chain that will prepare the industry for what comes next.
Key Learning Objectives
Who Should Attend
Speaker:
Gabrielle Gehron
Scientific Support Manager
Datwyler
From 2015 through 2019, Gabrielle Gehron attended Widener University. In that time, she earned both a bachelor’s and master’s degree in biomedical engineering, graduating with honors. In May of 2019, she entered the pharmaceutical packaging industry in a technical customer service role, recommending and evaluating packaging components for major drug companies. Less than a year later, the COVID-19 pandemic began, and Gabrielle saw first-hand how supply chain disruptions were affecting both companies and patients.
In 2022, Gabrielle joined Datwyler’s Technical and Scientific Support team as a Scientific Support Manager, serving customers in the North American region and globally. With a current focus on biologics, biotech, and cell and gene therapy, Gabrielle helps her clients find the perfect packaging solutions for their specialized drug products.
Register Free: https://www.pharmtech.com/pt_w/lockdown-lessons
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.